Novel Coronavirus Pneumonia (COVID-19)
Conditions
Interventions
1:SARS-CoV-2 inactivated vaccine for COVID-19 convalescents
2:SARS-CoV-2 inactivated vaccine for healthy persons
Sponsors
Chongqing Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Axillary temperature <= 37.0 degree C; 2. Positive reslut of RT-qPCR test previouly and Negative result currently; 3. Negative result for HIV test; 4. In the judgement of investigator, participants who are eligible to vaccination and capable of giving personal signed informed consent.
Exclusion criteria
Exclusion criteria: 1. With history of severe adverse reaction associated with a vaccine and/or severe allergic reaction to any component of the study intervention(s); 2. Individuals with Acute diseases, severe chronic diseases or on acute onset of chronic diseases; 3. Women who are pregnant(HCG+), have family planning within 3 months or breastfeeding; 4. Individuals with uncontrolled epilepsy or other progressive neurological disorders, or a history of Guillain-Barre syndrome; 5. Immunocompromised individuals with known or suspected immunodeficiency, as determined; by history and/or laboratory/physical examination; 6. People who are known or suspected to be suffering from severe respiratory diseases, severe cardiovascular diseases, liver or kidney diseases; 7. Current use of antitumor drug or immunosuppressor; 8. Individuals with thrombocytopenia or hemorrhagic disease; 9. In the judgement of investigator, paiticipants who are not eligible to vaccination; 10. Individuals are participating other clinical trials; 11. COVID-19 convalescents with severe sequelae, eg: lung damage et al.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Levels of SARS-CoV-2-specific antibody;Neutralizing antibodytiter (NT50) to SARS-CoV-2 infection; | — |
Countries
China
Contacts
Public ContactAi-long Huang
Chongqing Medical University
Outcome results
None listed